Liver injury in critically ill patients with COVID-19: a case series.
作者信息
Cardoso Filipe S, Pereira Rui, Germano Nuno
机构信息
Intensive Care Unit, Curry Cabral Hospital, R. Beneficiencia N8, 1050-099, Lisbon, Portugal.
出版信息
Crit Care. 2020 May 5;24(1):190. doi: 10.1186/s13054-020-02924-4.
Abstract
摘要
相似文献
1
Liver injury in critically ill patients with COVID-19: a case series.新冠肺炎危重症患者的肝损伤：病例系列
Crit Care. 2020 May 5;24(1):190. doi: 10.1186/s13054-020-02924-4.
2
Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients.重症 COVID-19 患者尿液中存在 SARS-CoV-2 的情况罕见，且与急性肾损伤无关。
Crit Care. 2020 Sep 29;24(1):587. doi: 10.1186/s13054-020-03302-w.
3
High Respiratory Drive and Excessive Respiratory Efforts Predict Relapse of Respiratory Failure in Critically Ill Patients with COVID-19.高呼吸驱动和过度呼吸努力预示着新冠肺炎危重症患者呼吸衰竭的复发。
Am J Respir Crit Care Med. 2020 Oct 15;202(8):1173-1178. doi: 10.1164/rccm.202005-1582LE.
4
Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series.用于患有细胞因子释放综合征的危重症COVID-19患者的皮质类固醇：一个有限病例系列
Can J Anaesth. 2020 Oct;67(10):1462-1464. doi: 10.1007/s12630-020-01700-w. Epub 2020 May 11.
5
Impact of immunosuppression on mortality in critically ill COVID-19 patients.免疫抑制对危重症COVID-19患者死亡率的影响。
Br J Haematol. 2020 Nov;191(3):394-395. doi: 10.1111/bjh.17108. Epub 2020 Oct 26.
6
Transient complete heart block in a patient with critical COVID-19.一名重症新型冠状病毒肺炎患者出现短暂性完全性心脏传导阻滞。
Eur Heart J. 2020 Jun 7;41(22):2131. doi: 10.1093/eurheartj/ehaa307.
7
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.新型冠状病毒肺炎（COVID-19）重症患者中疑似侵袭性肺曲霉病的患病率。
Lancet Respir Med. 2020 Jun;8(6):e48-e49. doi: 10.1016/S2213-2600(20)30237-X. Epub 2020 May 20.
8
Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19.内皮病变由危重症患者的血浆诱导产生，并与重症 COVID-19 中的器官衰竭相关。
Circulation. 2020 Nov 10;142(19):1881-1884. doi: 10.1161/CIRCULATIONAHA.120.050907. Epub 2020 Sep 24.
9
[Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].[复杂心肌损伤对重症或危重症新型冠状病毒肺炎患者临床结局的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jun 24;48(6):456-460. doi: 10.3760/cma.j.cn112148-20200228-00137.
10
Prolonged illness after COVID-19.新冠病毒感染后的长期病症
Tidsskr Nor Laegeforen. 2020 Sep 29;140(14). doi: 10.4045/tidsskr.20.0753. Print 2020 Oct 13.
引用本文的文献
1
Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review.新冠肺炎患者 ICU 住院期间的急性肝损伤：叙事性综述。
World J Gastroenterol. 2022 Dec 21;28(47):6662-6688. doi: 10.3748/wjg.v28.i47.6662.
2
Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor.通过生物信息学和系统生物学分析识别新冠病毒病药物治疗中与炎症药物及药物相互作用相关的药物性肝损伤：孕烷X受体的作用
Front Pharmacol. 2022 Aug 1;13:804189. doi: 10.3389/fphar.2022.804189. eCollection 2022.
3
Changes in laboratory value improvement and mortality rates over the course of the pandemic: an international retrospective cohort study of hospitalised patients infected with SARS-CoV-2.大流行期间实验室指标改善和死亡率的变化：一项国际回顾性队列研究，纳入了感染 SARS-CoV-2 的住院患者。
BMJ Open. 2022 Jun 23;12(6):e057725. doi: 10.1136/bmjopen-2021-057725.
4
Epidemiology, Clinical Presentation and Treatment of Non-Hepatic Hyperammonemia in ICU COVID-19 Patients.重症监护病房中新冠病毒感染患者非肝性高氨血症的流行病学、临床表现及治疗
J Clin Med. 2022 May 5;11(9):2592. doi: 10.3390/jcm11092592.
5
Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units.2019年冠状病毒病大流行对重症监护病房的肝脏、肝脏疾病及肝移植项目的影响
World J Hepatol. 2021 Oct 27;13(10):1215-1233. doi: 10.4254/wjh.v13.i10.1215.
6
COVID-19: Pulmonary and Extra Pulmonary Manifestations.新型冠状病毒肺炎：肺及肺外表现。
Front Public Health. 2021 Sep 28;9:711616. doi: 10.3389/fpubh.2021.711616. eCollection 2021.
7
Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2.干扰素 alfa-2b 与洛匹那韦/利托那韦联合干扰素 alfa-2b 治疗 SARS-CoV-2 的疗效比较。
BMC Infect Dis. 2021 Aug 30;21(1):885. doi: 10.1186/s12879-021-06595-6.
8
Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients.肝肾功能损伤标志物异常指标可预测新冠病毒肺炎患者的病情严重程度
Infect Drug Resist. 2021 Aug 10;14:3029-3040. doi: 10.2147/IDR.S321915. eCollection 2021.
9
Liver injury in COVID-19: clinical features and treatment management.COVID-19 相关肝损伤：临床特征与治疗管理。
Virol J. 2021 Jun 9;18(1):121. doi: 10.1186/s12985-021-01593-1.
10
A comprehensive evaluation of early potential risk factors for disease aggravation in patients with COVID-19.全面评估 COVID-19 患者疾病恶化的早期潜在风险因素。
Sci Rep. 2021 Apr 13;11(1):8062. doi: 10.1038/s41598-021-87413-6.
本文引用的文献
1
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.西雅图地区危重症新冠患者-病例系列。
N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30.
2
COVID-19 and the liver: little cause for concern.新冠病毒与肝脏：无需过度担忧。
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):529-530. doi: 10.1016/S2468-1253(20)30084-4. Epub 2020 Mar 20.
3
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
4
Cholestatic Alterations in the Critically Ill: Some New Light on an Old Problem.危重病患者的胆汁淤积性改变：一个老问题的新启示。
Chest. 2018 Mar;153(3):733-743. doi: 10.1016/j.chest.2017.08.018. Epub 2017 Aug 26.
5
Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.危重病会引起循环胆汁酸升高，与肝转运体和核受体表达改变有关。
Hepatology. 2011 Nov;54(5):1741-52. doi: 10.1002/hep.24582.
Zotero 插件